Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

A rhabdoid-mimicking intrahepatic cholangiocarcinoma.

Sugano I, Senda T, Hayashi S, Okaya T, Yamazaki K, Ishida Y.

Pathol Int. 2013 Aug;63(8):422-4. doi: 10.1111/pin.12082. No abstract available.

PMID:
23957919
2.

[Pathologic diagnosis of malignant rhabdoid tumor of skin].

Huang H, Xu H, Zeng S, Yang W, Huang J, Wu Y, Xiong F, Zeng H.

Zhonghua Bing Li Xue Za Zhi. 2014 May;43(5):334-5. Review. Chinese. No abstract available.

PMID:
25030868
3.

[Intrahepatic sarcomatoid cholangiocarcinoma with osteoclast-like giant cells: report of a case].

Fan XS, Chen J, Wu HY, Qiu YD, Zhang WW, Kong WT.

Zhonghua Bing Li Xue Za Zhi. 2010 Sep;39(9):640-1. Chinese. No abstract available.

PMID:
21092600
4.

Case report: intrahepatic cholangiocarcinoma with rhabdoid transformation.

Honda M, Enjoji M, Sakai H, Yamamoto I, Tsuneyoshi M, Nawata H.

J Gastroenterol Hepatol. 1996 Aug;11(8):771-4.

PMID:
8872777
5.

Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16.

Kuroda H, Moritake H, Sawada K, Kuwahara Y, Imoto I, Inazawa J, Sugimoto T.

Cancer Genet Cytogenet. 2005 Apr 15;158(2):172-9.

PMID:
15796965
6.

SMARCB1/INI1 alterations and hepatoblastoma: another extrarenal rhabdoid tumor revealed?

Russo P, Biegel JA.

Pediatr Blood Cancer. 2009 Mar;52(3):312-3. doi: 10.1002/pbc.21893. No abstract available.

7.

Immunohistochemical study as a tool in differential diagnosis of pediatric malignant rhabdoid tumor.

Machado I, Noguera R, Santonja N, Donat J, Fernandez-Delgado R, Acevedo A, Baragaño M, Navarro S.

Appl Immunohistochem Mol Morphol. 2010 Mar;18(2):150-8. doi: 10.1097/PAI.0b013e3181b91a51.

PMID:
19770707
8.

Atypical teratoid rhabdoid tumor mimicking beta-catenin-positive nodular medulloblastoma.

Varlet P, Beaugrand A, Lacroix L, Lequin D, Pierron G, Puget S, Negretti L, Boddaert N, Grill J, Dufour C.

Acta Neuropathol. 2011 Mar;121(3):429-30. doi: 10.1007/s00401-010-0796-5. No abstract available.

PMID:
21229255
9.

Primary thoracic myxoid variant of extrarenal rhabdoid tumor in childhood.

Fowler DJ, Malone M, Chisholm J, Roebuck D, Sebire NJ.

Fetal Pediatr Pathol. 2006 May-Jun;25(3):159-68.

PMID:
17060192
10.

Uterine neoplasms composed of rhabdoid cells do not exhibit loss of INI1 immunoreactivity and are not related to childhood malignant rhabdoid tumor.

Al-Hussaini M, Hirschowitz L, McCluggage WG.

Int J Gynecol Pathol. 2008 Apr;27(2):236-42. doi: 10.1097/PGP.0b013e31815aca67.

PMID:
18317218
11.

Renal sclerosing perivascular epithelioid cell tumor (PEComa)/angiomyolipoma with extensive rhabdoid cell features.

Miyai K, Mullick SS, Divatia MK, Shen SS, Ayala AG, Ro JY.

Pathol Int. 2014 May;64(5):247-50. doi: 10.1111/pin.12155. No abstract available.

PMID:
24888780
12.

Necrotic rhabdoid meningiomas with aggressive clinical behavior.

Matyja E, Grajkowska W, Nauman P, Bonicki W, Bojarski P, Marchel A.

Clin Neuropathol. 2010 Sep-Oct;29(5):307-16.

PMID:
20860894
13.

ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.

Kohashi K, Yamada Y, Hotokebuchi Y, Yamamoto H, Taguchi T, Iwamoto Y, Oda Y.

Hum Pathol. 2015 Feb;46(2):225-30. doi: 10.1016/j.humpath.2014.10.010.

PMID:
25479928
14.

Malignant rhabdoid tumor mimicking hepatoblastoma: a case report and literature review.

Wagner LM, Garrett JK, Ballard ET, Hill DA, Perry A, Biegel JA, Collins MH.

Pediatr Dev Pathol. 2007 Sep-Oct;10(5):409-15.

PMID:
17929989
15.

Sarcomatoid renal cell carcinoma with rhabdoid features.

Al-Saidi NA, Akhtar M.

Ann Saudi Med. 2013 Sep-Oct;33(5):495-9. doi: 10.5144/0256-4947.2013.495.

16.

Cholangiocarcinoma occurring in a liver with multiple bile duct hamartomas (von Meyenburg complexes).

Röcken C, Pross M, Brucks U, Ridwelski K, Roessner A.

Arch Pathol Lab Med. 2000 Nov;124(11):1704-6. Review.

PMID:
11079031
17.

Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors.

Algar EM, Muscat A, Dagar V, Rickert C, Chow CW, Biegel JA, Ekert PG, Saffery R, Craig J, Johnstone RW, Ashley DM.

PLoS One. 2009;4(2):e4482. doi: 10.1371/journal.pone.0004482.

18.

α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.

Ikeda H, Sato Y, Yoneda N, Harada K, Sasaki M, Kitamura S, Sudo Y, Ooi A, Nakanuma Y.

Hum Pathol. 2012 Nov;43(11):1955-63. doi: 10.1016/j.humpath.2011.11.022.

PMID:
22516245
19.

A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma.

Kai K, Ide Y, Miyoshi A, Masuda M, Ide T, Kitahara K, Irie H, Nakajima J, Noshiro H, Tokunaga O.

Pathol Int. 2013 Aug;63(8):419-21. doi: 10.1111/pin.12081. No abstract available.

PMID:
23957918
20.

SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features.

Cho YM, Choi J, Lee OJ, Lee HI, Han DJ, Ro JY.

Pathol Int. 2006 Nov;56(11):702-6.

PMID:
17040295
Items per page

Supplemental Content

Support Center